The University of Chicago Header Logo

Katharine Yao

Concepts (280)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mastectomy
48
2023
243
15.110
Why?
Breast Neoplasms
85
2023
2904
15.090
Why?
Carcinoma, Ductal, Breast
22
2022
157
7.690
Why?
Carcinoma, Lobular
18
2019
81
6.300
Why?
Mastectomy, Segmental
18
2023
93
4.340
Why?
Surgeons
11
2023
233
4.030
Why?
Mammaplasty
10
2023
107
3.240
Why?
Prophylactic Mastectomy
8
2020
13
3.030
Why?
Neoadjuvant Therapy
8
2019
318
2.940
Why?
Neoplasm Staging
25
2019
1938
2.690
Why?
Carcinoma, Intraductal, Noninfiltrating
7
2022
113
2.470
Why?
Quality Indicators, Health Care
5
2021
145
2.150
Why?
Lymph Node Excision
10
2021
217
2.090
Why?
Receptors, Estrogen
10
2022
384
2.070
Why?
Surgical Oncology
4
2020
27
2.030
Why?
Sentinel Lymph Node Biopsy
12
2021
68
2.010
Why?
Radiation Oncology
3
2021
119
1.980
Why?
Female
88
2023
44566
1.980
Why?
Cancer Care Facilities
3
2020
28
1.970
Why?
Databases, Factual
18
2018
816
1.920
Why?
Middle Aged
63
2023
25027
1.910
Why?
Prognosis
25
2020
3681
1.900
Why?
Accreditation
3
2019
60
1.880
Why?
Time-to-Treatment
3
2021
98
1.780
Why?
Practice Guidelines as Topic
7
2019
1037
1.760
Why?
Guideline Adherence
4
2018
224
1.650
Why?
Follow-Up Studies
21
2020
3639
1.630
Why?
Neoplasm Recurrence, Local
9
2020
1313
1.620
Why?
Aged
49
2023
18407
1.610
Why?
Aged, 80 and over
33
2018
6511
1.580
Why?
Chemotherapy, Adjuvant
8
2019
468
1.540
Why?
Radiotherapy, Adjuvant
9
2021
292
1.530
Why?
Humans
97
2023
86656
1.500
Why?
Unilateral Breast Neoplasms
4
2020
5
1.470
Why?
Mastectomy, Subcutaneous
2
2022
8
1.430
Why?
Nipples
6
2022
37
1.390
Why?
Thoracic Wall
2
2018
21
1.300
Why?
Receptor, ErbB-2
5
2019
224
1.290
Why?
Adult
44
2023
25648
1.260
Why?
Lymph Nodes
4
2018
533
1.240
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2019
2438
1.240
Why?
Practice Patterns, Physicians'
5
2020
584
1.160
Why?
Decision Support Techniques
2
2019
160
1.140
Why?
Neoplasm Invasiveness
9
2020
552
1.130
Why?
Ergonomics
3
2022
21
1.120
Why?
United States
26
2022
6674
1.100
Why?
Combined Modality Therapy
8
2021
1686
1.080
Why?
Decision Making
4
2019
643
1.060
Why?
Breast
6
2021
288
1.030
Why?
Biomarkers, Tumor
5
2019
1464
1.030
Why?
Axilla
11
2021
99
1.020
Why?
Receptors, Progesterone
6
2019
167
1.020
Why?
Neoplasms, Second Primary
3
2017
252
1.000
Why?
Survival Rate
12
2018
1864
0.990
Why?
Retrospective Studies
23
2020
8476
0.990
Why?
Surveys and Questionnaires
8
2023
2502
0.960
Why?
Attitude of Health Personnel
4
2023
636
0.910
Why?
Brachytherapy
2
2014
119
0.880
Why?
Carcinoma
2
2017
436
0.880
Why?
Breast Neoplasms, Male
1
2022
30
0.860
Why?
Organ Sparing Treatments
2
2019
38
0.830
Why?
Medical Overuse
2
2019
36
0.820
Why?
Neoplasm Grading
10
2018
357
0.790
Why?
Oncologists
1
2021
36
0.750
Why?
Quality of Health Care
3
2018
381
0.750
Why?
Young Adult
13
2023
5977
0.710
Why?
Burnout, Professional
1
2021
94
0.690
Why?
Healthcare Disparities
2
2015
372
0.690
Why?
Lymphatic Metastasis
7
2018
486
0.680
Why?
Age Factors
9
2018
1849
0.680
Why?
Antineoplastic Agents, Hormonal
3
2017
150
0.670
Why?
Stereotaxic Techniques
1
2019
69
0.660
Why?
Prophylactic Surgical Procedures
2
2015
7
0.660
Why?
Image-Guided Biopsy
1
2019
66
0.650
Why?
Patient Selection
6
2019
686
0.650
Why?
Patient Satisfaction
4
2016
454
0.650
Why?
Pneumonia, Viral
2
2020
315
0.630
Why?
Coronavirus Infections
2
2020
300
0.630
Why?
Reoperation
5
2015
593
0.630
Why?
Consensus
2
2016
336
0.620
Why?
Patient Care
1
2019
100
0.620
Why?
Radiography, Interventional
1
2019
150
0.620
Why?
Patient Transfer
1
2018
91
0.620
Why?
Genes, BRCA2
3
2016
160
0.620
Why?
Patient Reported Outcome Measures
4
2020
164
0.610
Why?
Genes, BRCA1
3
2016
192
0.610
Why?
Hospitals, Low-Volume
1
2017
18
0.610
Why?
Patient Acceptance of Health Care
2
2017
238
0.600
Why?
Hospitals, High-Volume
1
2017
35
0.590
Why?
Radiotherapy, Conformal
1
2017
83
0.580
Why?
Patient Preference
4
2019
105
0.570
Why?
Logistic Models
7
2017
1185
0.560
Why?
Postoperative Complications
7
2016
2204
0.560
Why?
Societies, Medical
2
2019
573
0.540
Why?
Health Knowledge, Attitudes, Practice
2
2019
508
0.520
Why?
Prospective Studies
8
2022
4212
0.510
Why?
Estrogen Receptor alpha
2
2013
144
0.500
Why?
Quality of Life
4
2019
1587
0.500
Why?
Adolescent
8
2023
8988
0.460
Why?
Patient Education as Topic
1
2016
351
0.460
Why?
Elective Surgical Procedures
1
2014
117
0.440
Why?
Length of Stay
3
2015
704
0.430
Why?
Receptors, Notch
2
2010
123
0.420
Why?
Cross-Sectional Studies
4
2021
1618
0.420
Why?
Melanoma
2
2009
459
0.420
Why?
Radiotherapy, Intensity-Modulated
1
2013
173
0.410
Why?
Skin Neoplasms
2
2009
546
0.400
Why?
Registries
1
2014
703
0.390
Why?
Workload
2
2022
128
0.380
Why?
Operating Rooms
2
2022
126
0.380
Why?
Patient Readmission
1
2014
329
0.370
Why?
Receptor, Notch1
2
2010
94
0.370
Why?
Gelatin Sponge, Absorbable
1
2008
3
0.340
Why?
Patients
2
2023
100
0.340
Why?
Breast Diseases
1
2008
97
0.320
Why?
Socioeconomic Factors
3
2016
567
0.320
Why?
Quality Control
2
2019
117
0.310
Why?
Breast Implantation
3
2016
12
0.300
Why?
Proto-Oncogene Proteins
2
2010
645
0.300
Why?
Calcinosis
1
2008
226
0.300
Why?
Pilot Projects
3
2019
840
0.280
Why?
SEER Program
3
2017
190
0.280
Why?
Risk Factors
6
2019
5416
0.280
Why?
Randomized Controlled Trials as Topic
3
2017
864
0.270
Why?
Multivariate Analysis
4
2018
999
0.270
Why?
Risk Assessment
4
2020
2261
0.260
Why?
Health Care Surveys
2
2018
278
0.260
Why?
Magnetic Resonance Imaging
1
2017
3366
0.250
Why?
Proportional Hazards Models
3
2017
860
0.250
Why?
Referral and Consultation
2
2019
328
0.250
Why?
Biopsy
3
2014
1163
0.230
Why?
Self Concept
1
2023
133
0.220
Why?
Time Factors
5
2016
5215
0.220
Why?
Pandemics
4
2022
737
0.220
Why?
Radiotherapy Dosage
2
2014
468
0.220
Why?
Cohort Studies
4
2018
2765
0.190
Why?
Male
8
2022
40995
0.190
Why?
Gene Expression Profiling
2
2019
1387
0.190
Why?
Mammography
2
2017
463
0.180
Why?
Betacoronavirus
2
2020
257
0.180
Why?
Personnel Selection
1
2020
59
0.180
Why?
Longitudinal Studies
2
2020
1019
0.170
Why?
Minimally Invasive Surgical Procedures
2
2018
237
0.170
Why?
Health Resources
1
2020
76
0.170
Why?
Body Image
1
2019
76
0.170
Why?
Triage
1
2020
108
0.170
Why?
Specialties, Surgical
1
2020
64
0.170
Why?
Fear
1
2019
78
0.170
Why?
Uterine Cervical Neoplasms
1
2022
275
0.170
Why?
Treatment Outcome
5
2018
7982
0.170
Why?
Fellowships and Scholarships
1
2020
110
0.170
Why?
Interviews as Topic
1
2020
319
0.170
Why?
Breast Implants
2
2016
23
0.170
Why?
User-Computer Interface
1
2020
185
0.170
Why?
Anxiety
1
2021
286
0.170
Why?
Video Recording
1
2019
190
0.160
Why?
Neoplasm Micrometastasis
1
2018
5
0.160
Why?
Databases as Topic
1
2018
92
0.160
Why?
Emotions
1
2021
341
0.160
Why?
Patient Participation
1
2019
216
0.150
Why?
Telemedicine
1
2020
168
0.150
Why?
Patient Compliance
1
2018
228
0.150
Why?
Heterozygote
2
2016
366
0.150
Why?
Choice Behavior
1
2018
160
0.150
Why?
Sleep
1
2021
444
0.140
Why?
Odds Ratio
1
2018
679
0.140
Why?
Surgical Wound Infection
2
2015
182
0.140
Why?
Ultrasonography, Mammary
1
2017
82
0.140
Why?
Disease Management
1
2018
328
0.140
Why?
Radiotherapy Planning, Computer-Assisted
1
2017
176
0.140
Why?
Esthetics
1
2016
44
0.140
Why?
Illinois
1
2017
462
0.140
Why?
Watchful Waiting
1
2016
60
0.140
Why?
Molecular Typing
1
2015
17
0.130
Why?
Comprehension
1
2016
79
0.130
Why?
Europe
1
2016
309
0.130
Why?
Neoplasms
2
2022
2898
0.130
Why?
Remission Induction
1
2017
722
0.130
Why?
Pharyngectomy
1
2015
8
0.130
Why?
Population Surveillance
1
2016
219
0.130
Why?
Immunohistochemistry
2
2010
1759
0.130
Why?
Counseling
1
2016
145
0.130
Why?
Physicians
2
2019
673
0.130
Why?
Carcinoma in Situ
1
2015
53
0.120
Why?
Selection Bias
1
2014
37
0.120
Why?
Linear Models
1
2015
421
0.120
Why?
Chemoradiotherapy
1
2017
301
0.120
Why?
Neoplasm Metastasis
1
2018
1056
0.120
Why?
Colorectal Neoplasms
1
2022
938
0.120
Why?
Case-Control Studies
2
2018
1809
0.120
Why?
Incidence
2
2017
1578
0.120
Why?
Cost-Benefit Analysis
1
2016
453
0.120
Why?
Adipokines
1
2013
19
0.120
Why?
Receptor, Notch4
2
2010
5
0.110
Why?
Insurance, Health
1
2014
160
0.110
Why?
Oropharyngeal Neoplasms
1
2015
118
0.110
Why?
Robotic Surgical Procedures
1
2018
267
0.110
Why?
Kaplan-Meier Estimate
1
2015
861
0.110
Why?
Fatty Acids
1
2013
130
0.110
Why?
Surgical Flaps
1
2015
241
0.110
Why?
Venous Thromboembolism
1
2015
152
0.110
Why?
Adipose Tissue
1
2013
241
0.100
Why?
Health Services Accessibility
1
2014
394
0.100
Why?
Models, Biological
1
2018
1752
0.090
Why?
Reproducibility of Results
1
2017
2704
0.090
Why?
Serrate-Jagged Proteins
1
2010
13
0.090
Why?
Jagged-1 Protein
1
2010
13
0.090
Why?
Gene Expression Regulation, Neoplastic
1
2015
1197
0.090
Why?
Head and Neck Neoplasms
1
2017
1052
0.090
Why?
Calcium-Binding Proteins
1
2010
119
0.090
Why?
Lung Neoplasms
1
2022
2262
0.090
Why?
Intercellular Signaling Peptides and Proteins
1
2010
180
0.090
Why?
False Positive Reactions
1
2008
216
0.080
Why?
Receptor Cross-Talk
1
2008
33
0.080
Why?
Early Detection of Cancer
2
2022
395
0.080
Why?
Quality Improvement
2
2022
427
0.080
Why?
Hemostatics
1
2008
56
0.080
Why?
Neoplastic Cells, Circulating
1
2008
70
0.080
Why?
Interferon-alpha
1
2009
234
0.080
Why?
Biopsy, Needle
1
2008
234
0.080
Why?
Carcinoma, Squamous Cell
1
2015
1077
0.080
Why?
Hyperplasia
1
2008
148
0.080
Why?
Chi-Square Distribution
1
2008
364
0.080
Why?
Cancer Vaccines
1
2009
156
0.080
Why?
Immunologic Factors
1
2009
170
0.080
Why?
Drug Delivery Systems
1
2008
178
0.070
Why?
Obesity
1
2013
964
0.070
Why?
RNA, Messenger
1
2012
1988
0.070
Why?
Analysis of Variance
1
2008
911
0.070
Why?
Disease-Free Survival
2
2011
1204
0.070
Why?
Sensitivity and Specificity
1
2008
1991
0.060
Why?
Membrane Proteins
1
2010
1201
0.060
Why?
Predictive Value of Tests
1
2008
1672
0.060
Why?
Mutation
1
2014
3977
0.060
Why?
Immunoenzyme Techniques
2
2013
303
0.050
Why?
Qualitative Research
1
2023
256
0.050
Why?
Organizational Innovation
1
2020
41
0.050
Why?
Tumor Cells, Cultured
2
2013
1041
0.040
Why?
Genetic Testing
1
2023
535
0.040
Why?
Program Evaluation
1
2020
297
0.040
Why?
Fees and Charges
1
2018
14
0.040
Why?
Hospital Charges
1
2018
29
0.040
Why?
Sentinel Lymph Node
1
2018
15
0.040
Why?
Mass Screening
1
2022
619
0.040
Why?
Propensity Score
1
2018
136
0.040
Why?
Area Under Curve
1
2018
334
0.040
Why?
Urologic Surgical Procedures
1
2018
146
0.040
Why?
Postoperative Care
1
2017
221
0.030
Why?
Tumor Burden
1
2017
290
0.030
Why?
Chicago
1
2020
1380
0.030
Why?
ROC Curve
1
2018
752
0.030
Why?
Cell Proliferation
2
2013
1596
0.030
Why?
Prostatectomy
1
2018
471
0.030
Why?
Self Report
1
2016
288
0.030
Why?
Communication
1
2018
440
0.030
Why?
Prosthesis Failure
1
2015
110
0.030
Why?
Blood Transfusion
1
2015
157
0.030
Why?
Lipase
1
2013
22
0.030
Why?
Serpins
1
2013
29
0.030
Why?
Transplantation, Autologous
1
2015
331
0.030
Why?
Nerve Growth Factors
1
2013
63
0.030
Why?
Risk
1
2015
674
0.030
Why?
Leptin
1
2013
104
0.030
Why?
Physician-Patient Relations
1
2018
610
0.030
Why?
Ki-67 Antigen
1
2012
64
0.030
Why?
Microarray Analysis
1
2012
96
0.030
Why?
Eye Proteins
1
2013
128
0.030
Why?
Contraindications
1
2012
72
0.030
Why?
In Situ Hybridization, Fluorescence
1
2012
349
0.030
Why?
Sepsis
1
2015
307
0.020
Why?
Comorbidity
1
2015
945
0.020
Why?
Body Mass Index
1
2013
768
0.020
Why?
Neoplasms, Hormone-Dependent
1
2008
40
0.020
Why?
Estradiol
1
2008
252
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
458
0.020
Why?
RNA, Small Interfering
1
2008
547
0.020
Why?
Mice, Nude
1
2008
789
0.020
Why?
Mice, Inbred BALB C
1
2008
1059
0.020
Why?
Mice
1
2008
11439
0.010
Why?
Animals
1
2008
26706
0.010
Why?
Yao's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (280)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_